Wafik S. El‐Deiry
Impact in
- Oncology top 0.01%
- Cancer-related Molecular Pathways
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 363
- Cancer-related Molecular Pathways 199
- Colorectal Cancer Treatments and Studies 40
- Cancer Cells and Metastasis 39
-
- Cell death mechanisms and regulation 122
- Epigenetics and DNA Methylation 39
- Co-authors
- Victor E. Velculescu (4 shared papers)Benedito A. Carneiro (39 shared papers)K W Kinzler (3 shared papers)Takashi Tokino (2 shared papers)Zhaoyu Jin (9 shared papers)W E Mercer (1 shared paper)David Pei‐Cheng Lin (1 shared paper)Daniel B. Levy (1 shared paper)
- Journals
- Cancer Research (95 papers)Cancer Biology & Therapy (69 papers)Journal of Clinical Oncology (53 papers)Oncotarget (23 papers)Cell Cycle (21 papers)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
Wafik S. El‐Deiry
567 papers receiving 46.6k citations
Wafik S. El‐Deiry's Hit Papers
Peers
Comparison fields: 5 of 176
- Oncology 21.5k
- Cancer Research 8.4k
- Biotechnology 4.3k
- Molecular Biology 30.9k
- Immunology 4.9k
Countries citing papers authored by Wafik S. El‐Deiry
This map shows the geographic impact of Wafik S. El‐Deiry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafik S. El‐Deiry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafik S. El‐Deiry more than expected).
Fields of papers citing papers by Wafik S. El‐Deiry
This network shows the impact of papers produced by Wafik S. El‐Deiry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafik S. El‐Deiry. The network helps show where Wafik S. El‐Deiry may publish in the future.
Co-authors
The 25 scholars most cited alongside Wafik S. El‐Deiry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 588 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | WAF1, a potential mediator of p53 tumor suppression Hit paper breakdown → | 1993 | 7238 |
| 2 | A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Hit paper breakdown → | 1992 | 2654 |
| 3 | Targeting apoptosis in cancer therapy Hit paper breakdown → | 2020 | 1919 |
| 4 | WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Hit paper breakdown → | 1994 | 1791 |
| 5 | Definition of a consensus binding site for p53 Hit paper breakdown → | 1992 | 1696 |
| 6 | Overview of cell death signaling pathways Hit paper breakdown → | 2005 | 1055 |
| 7 | FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis Hit paper breakdown → | 1998 | 759 |
| 8 | TRAIL and apoptosis induction by TNF-family death receptors Hit paper breakdown → | 2003 | 725 |
| 9 | Regulation ofp53downstream genes Hit paper breakdown → | 1998 | 673 |
| 10 | Acoustic separation of circulating tumor cells Hit paper breakdown → | 2015 | 646 |
| 11 | Classification of cell death: recommendations of the Nomenclature Committee on Cell Death Hit paper breakdown → | 2005 | 606 |
| 12 | Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Hit paper breakdown → | 1995 | 526 |
| 13 | Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting Hit paper breakdown → | 2021 | 467 |
| 14 | 1997 | 431 | |
| 15 | 2003 | 418 | |
| 16 | 1998 | 395 | |
| 17 | 1995 | 366 | |
| 18 | p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Hit paper breakdown → | 1994 | 358 |
| 19 | Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. | 1997 | 358 |
| 20 | 1994 | 351 |
About Wafik S. El‐Deiry
Wafik S. El‐Deiry is a scholar working on Oncology, Molecular Biology, Cancer Research, Biotechnology and Pulmonary and Respiratory Medicine, having authored 588 papers that have together received 47.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (199 papers), Cell death mechanisms and regulation (122 papers), Cancer Research and Treatments (82 papers), Cancer Genomics and Diagnostics (45 papers), Cancer, Hypoxia, and Metabolism (41 papers), Colorectal Cancer Treatments and Studies (40 papers), Cancer Cells and Metastasis (39 papers) and Epigenetics and DNA Methylation (39 papers). The work is most often cited by research in Oncology (21.5k citations), Cancer Research (8.4k citations), Biotechnology (4.3k citations), Molecular Biology (30.9k citations) and Immunology (4.9k citations). Wafik S. El‐Deiry has collaborated with scholars based in United States, India and France. Frequent co-authors include Victor E. Velculescu, Benedito A. Carneiro, K W Kinzler, Takashi Tokino, Zhaoyu Jin, W E Mercer, David Pei‐Cheng Lin, Daniel B. Levy, Bert Vogelstein and J.M. Trent. Their work appears in journals such as Cancer Research, Cancer Biology & Therapy, Journal of Clinical Oncology, Oncotarget and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.